Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DP4J2K
|
|||
| Drug Name |
MRx0518
|
|||
| Drug Type |
Live biotherapeutic product
|
|||
| Indication | Non-small-cell lung cancer [ICD-11: 2C25] | Phase 1/2 | [1] | |
| Company |
4D Pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03637803) Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.